NFKB1 and atherosclerosis: Vascular inflammation is known to be at the center of atherosclerosis and, in this context, anti-inflammatory effects become important as it was shown in the cerebral aneurysm models in rats that pitavastatin managed to reduce NF-κB activation [16, 17].